We are live on ! Find out more
ALZN icon

Alzamend Neuro
ALZN

22 hedge funds and large institutions have $1.49M invested in Alzamend Neuro in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

10% more funds holding

Funds holding: 20 → 22 (+2)

0% more ownership

Funds ownership: 0% → 0% (+0%)

52% less capital invested

Capital invested by funds: $3.13M → $1.49M (-$1.64M)

Holders
22
Holders Change
+2
Holders Change %
+10%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
1
Closed
3
Calls
$20K
Puts
–
Net Calls
+$20K
Net Calls Change
-$37K

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$25.3K
2
TRCT
Tower Research Capital (TRC)
New York
+$11K
3
Millennium Management
Millennium Management
New York
+$9.56K
4
Renaissance Technologies
Renaissance Technologies
New York
+$7.65K
5
FIA
Foundations Investment Advisors
Arizona
+$7.17K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$11K
2
CSS
Cubist Systematic Strategies
Connecticut
-$5.36K
3
Group One Trading
Group One Trading
Illinois
-$1.91K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$478
Name Holding Trade Value Shares
Change 		Change in
Stake
Truist Financial
1
Truist Financial
North Carolina
$549K – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$482K -$478 -1 -0.1%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$151K +$25.3K +53 +13%
BlackRock
4
BlackRock
New York
$141K – – –
RA
5
RFG Advisory
Alabama
$59.3K – – –
Northern Trust
6
Northern Trust
Illinois
$24.6K – – –
Charles Schwab
7
Charles Schwab
California
$12.6K – – –
TRCT
8
Tower Research Capital (TRC)
New York
$11.5K +$11K +23 +177%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$9.57K – – –
IIC
10
Integrated Investment Consultants
Michigan
$9.48K – – –
State Street
11
State Street
Massachusetts
$7.56K – – –
TSS
12
Two Sigma Securities
New York
$6.67K +$1.91K +4 +24%
Millennium Management
13
Millennium Management
New York
$6.55K +$9.56K +20 New
Renaissance Technologies
14
Renaissance Technologies
New York
$5K +$7.65K +16 New
FIA
15
Foundations Investment Advisors
Arizona
$4.74K +$7.17K +15 New
Commonwealth Equity Services
16
Commonwealth Equity Services
Massachusetts
$4K – – –
XT
17
XTX Topco
Cayman Islands
$3.08K +$4.78K +10 New
IWS
18
Insight Wealth Strategies
California
$2.37K – – –
UBS Group
19
UBS Group
Switzerland
$1.88K +$2.87K +6 New
IA
20
IFP Advisors
Florida
$1.19K – – –
HIA
21
Harbor Investment Advisory
Maryland
$711 – – –
Osaic Holdings
22
Osaic Holdings
Arizona
$237 – – –
Morgan Stanley
23
Morgan Stanley
New York
$119 – – –
Wells Fargo
24
Wells Fargo
California
$117 – – –
Fidelity Investments
25
Fidelity Investments
Massachusetts
$64 – – –
1
2

ALZN Hedge Fund Activity: Q3 2023 in Review

22 of the 6,303 institutional investors tracked by Wall St. Rank reported a position in Alzamend Neuro (ALZN) for Q3 2023, worth a combined $1.49M — down 52% from $3.13M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ALZN positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $25.3K. The largest seller was Virtu Financial, exiting entirely with an estimated $11K sold.

  • 22 institutional investors held Alzamend Neuro (ALZN) as of Q3 2023, up from 20 in Q2 2023.
  • Funds reported $1.49M of Alzamend Neuro stock for Q3 2023, down 52% quarter-over-quarter.
  • 5 funds opened new Alzamend Neuro positions in Q3 2023 and 3 closed out, a net change of +2 holders.
  • The largest Alzamend Neuro buyer in Q3 2023 was Geode Capital Management, an estimated $25.3K added.
  • The largest Alzamend Neuro seller in Q3 2023 was Virtu Financial, an estimated $11K sold.

Based on aggregated 13F filings for Q3 2023.